Approved Sale Expenses. Obagi shall bear its pro-rata share (based upon the number of shares sold) of the reasonable out-of-pocket costs of an sale of Co-Sale Stock pursuant to an Approved Sale to the extent such costs are incurred for the benefit of all holders of Co-Sale Stock and are not otherwise paid by the Company or the acquiring party.
Appears in 4 contracts
Samples: Investors’ Rights Agreement (Obagi Medical Products, Inc.), Investors’ Rights Agreement (Obagi Medical Products, Inc.), Investors’ Rights Agreement (Obagi Medical Products, Inc.)
